Gilenya Labels to be Updated to Include Warnings for PML Cases
- FDA Drug Safety Communication: FDA warns about cases of rare brain infection with MS drug Gilenya (fingolimod) in two patients with no prior exposure to immunosuppressant drugs. The Food and Drug Administration. Published August 4, 2015. Accessed August 5, 2015.
- Barber J. Label of Novartis' Gilenya to be updated after FDA warns of PML cases. First Word Pharma. Published August 4, 2015. Accessed August 5, 2015.